Status:

UNKNOWN

Research on Hybrid Operation Technique in the Treatment of Complex Brain Arteriovenous Malformations

Lead Sponsor:

Ministry of Science and Technology of the People´s Republic of China

Conditions:

Cerebrovascular Disease

Arteriovenous Malformations

Eligibility:

All Genders

Up to 70 years

Phase:

NA

Brief Summary

Complex brain arteriovenous malformations (bAVMs) in ≥3 Spetzler-Martin grades have long been challenges among cerebrovascular diseases. None of the traditional methods, such as microsurgical operatio...

Detailed Description

The study is being conducted from Jan 2016 to Dec 2020 with 20 cooperation units. It consists of 2 sets. The registry set is designed as a prospective real-world registry. The trial set is designed as...

Eligibility Criteria

Inclusion

  • patients of all ages;
  • diagnosed with arteriovenous malformations (AVMs) in brain parenchyma (including cerebrum and cerebellum) by DSA, with/without dura arteriovenous fistula;
  • with any operative indications as follows: (1) with stable hematoma or history of hemorrhage due to bAVMs, and allowed selective operation; (2) with recurrent epilepsy seizure, having failed treatment with antiepileptic drugs (AEDs); (3) with induced deterioration of neurological functions;
  • with Spetzler-Martin Grades from I to IV;
  • who provide informed consent.

Exclusion

  • \>70 years old with no significant hemorrhagic risk of bAVMs;
  • with Spetzler-Martin Grade ≥V;
  • accompanied by severe chronic disease, organ dysfunction, or malignant tumor that cannot tolerate the operation;
  • allergic to iodinated contrast agent;
  • unable to give informed consent.

Key Trial Info

Start Date :

January 1 2016

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2020

Estimated Enrollment :

1200 Patients enrolled

Trial Details

Trial ID

NCT03774017

Start Date

January 1 2016

End Date

December 31 2020

Last Update

December 12 2018

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

Xuanwu Hospital, Capital Medical University

Beijing, Beijing Municipality, China, 100053

2

Beijing Tiantan Hospital Capital Medical University

Beijing, Beijing Municipality, China, 100070

3

General Hospital of Rocket Army

Beijing, Beijing Municipality, China, 100088

4

Qilu Hospital, Shandong University

Jinan, Shandong, China, 250012